NAACCR Item #3804: Adenopathy
|Item #||Length||Source of Standard||Year Implemented||Version Implemented||Year Retired||Version Retired|
NAACCR XML: Tumor.adenopathy
RAI Classification: Adenopathy
Adenopathy is defined as the presence of lymph nodes greater than 1.5 cm on physical examination (PE) and is part of the staging criteria for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).
Adenopathy is a prognostic factor required for staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in AJCC 8th edition, Chapter 79, Hodgkin and Non-Hodgkin Lymphomas.
|0||Adenopathy not identified/not present|
No lymph nodes >1.5 cm
Physician states Rai Stage 0
Presence of lymph nodes >1.5 cm
Physician stated Rai Stage I
|5||Not applicable: Primary site is not C421|
|9||Not documented in medical record|
Adenopathy not assessed or unknown if assessed
No Rai stage is documented in the record and there is no documentation of adenopathy
Physician states Rai stage II-IV and there is no documentation of adenopathy
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.